Skip to content
Search

Latest Stories

'Our future pharmacists deserve better', sector lambasts GPhC for failing foundation exam candidates

The General Pharmaceutical Council has apologized for severe delays and disruptions during the June foundation registration assessment at five test centres in England on Wednesday (June 29).

The pharmacy regulator said it has since "contacted the candidates affected via email to apologise for the disruption and the extra worry this will have caused.


"We will also be issuing our usual survey for all candidates so we can hear directly from them about their experiences and have also asked candidates to get in touch if they would like individual advice."

GPhC admitted that the worse sufferers were the candidates at a test centre in Nottingham "where the delay was severe and candidates were only able to start Paper 1 in the late afternoon".

Extremely sorry

In a statement, Duncan Rudkin, chief executive of the GPhC, said: “We are extremely sorry for the severe delays experienced by candidates in Nottingham today. This is completely unacceptable, and we fully appreciate the significant stress and disruption this must have caused for them in such a high-stakes assessment.

“We are advising the candidates in Nottingham that we will accept the severe delay as grounds for appeal if they do not pass. This means that if they do not pass the assessment, this sitting would not count as one of their attempts to pass. We are considering what else we can do to support the affected candidates.

“The GPhC and BTL will also work together as a priority to review what caused these delays and make sure lessons are learnt to help avoid these issues happening again in the future.”

Nisha's ordeal

A candidate took to Twitter to complain: "Left the Notts #gphcexam at 11pm, was in the building for 14 hrs, sat for 8 hrs in starvation waiting to sit the exam-was made to press end test 30 mins before my exam timer was up because they ‘had to close the building’, didn’t get to read the last 22 questions.

Pharmacy Business has asked GPhC how it will compensate the affected candidates like Nisha.

GPhC has since tried to reach out to Nisha via Twitter -- apologising for her "completely unacceptable experience" and dealing with her case "as a matter of urgency".

The pharmacy regulator says that the majority of the just under 2,700 registration exam candidates "were able to complete the assessment with no issues". Those in five test centres -- of a total of 113 centres across the UK -- "experienced delays in starting either Paper 1 or Paper 2 due to IT or other technical issues".

'We need better systems'

Commenting on the difficulties and delays experienced by candidates in five centres in England, Royal Pharmaceutical Society president Claire Anderson said: “The registration examination is the gateway to our profession. It exists to preserve the profession’s integrity and protect patients, and as such there must be confidence in it. After continued issues over multiple sittings, however, the profession is losing this trust... Our future pharmacists deserve better. The GPhC must ensure no trainee ever has this kind of experience again.”

Senior pharmacist Mohammed Hussain tweeted: "This must just be awful for the candidates. Five years leading to this and then they have to stay quarantined for several hours in a room, stressed, waiting for the the exam to start. These failures keep happening, we need better systems and mitigations.".

Meanwhile, the profession's charity, Pharmacist Support, has offered help to those affected by the exam chaos. "We're sorry to hear of the issues that went on with the registration assessment. Please remember we are here to support you with your wellbeing."

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less